Tae Ryong Kim

Title: Tae Ryong Kim: Innovator in Pharmaceutical Composition

Introduction

Tae Ryong Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing the stability and efficacy of pharmaceutical formulations.

Latest Patents

Tae Ryong Kim holds a patent for an oral pharmacological composition that includes a novel compound, 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone. This compound is characterized by its crystalline structure, which offers excellent stability. The patent outlines a pharmaceutical composition that includes this compound as a major ingredient, along with a pharmaceutically acceptable diluent and lubricant. The advantages of this composition include good stability, high dissolution rate, improved content uniformity, and excellent pharmacokinetic properties. It is particularly effective as a non-steroidal anti-inflammatory drug for treating inflammation or pain.

Career Highlights

Tae Ryong Kim is associated with Crystalgenomics, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that meet the needs of patients and healthcare providers.

Collaborations

Some of his notable coworkers include Byung-Ha Kim and Sik Ii Ahn, who have collaborated with him on various projects within the company.

Conclusion

Tae Ryong Kim's contributions to pharmaceutical innovations highlight his commitment to improving drug efficacy and stability. His patent reflects a significant advancement in the field, showcasing the potential for better treatment options for patients.